Literature DB >> 16164374

A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).

Parris Kidd1, Kathleen Head.   

Abstract

Certain of the water-soluble flavonoid molecules can be converted into lipid-compatible molecular complexes, aptly called phytosomes. Phytosomes are better able to transition from a hydrophilic environment into the lipid-friendly environment of the outer cell membrane, and from there into the cell, finally reaching the blood. The fruit of the milk thistle plant (Silybum marianum, Family Asteraceae) contains flavonoids that are proven liver protectants. The standardized extract known as silymarin contains three flavonoids of the flavonol subclass. Silybin predominates, followed by silydianin and silychristin. Although silybin is the most potent of the flavonoids in milk thistle, similar to other flavonoids it is not well-absorbed. Silybin-phosphatidylcholine complexed as a phytosome provides significant liver protection and enhanced bioavailability over conventional silymarin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164374

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  37 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 2.  Food-based natural products for cancer management: Is the whole greater than the sum of the parts?

Authors:  Suleman S Hussain; Addanki P Kumar; Rita Ghosh
Journal:  Semin Cancer Biol       Date:  2016-07-07       Impact factor: 15.707

Review 3.  Oxidative stress and antioxidants in hepatic pathogenesis.

Authors:  Hye-Lin Ha; Hye-Jun Shin; Mark A Feitelson; Dae-Yeul Yu
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.

Authors:  Bill Gurley; Martha A Hubbard; D Keith Williams; John Thaden; Yudong Tong; W Brooks Gentry; Philip Breen; Danielle J Carrier; Shreekar Cheboyina
Journal:  J Clin Pharmacol       Date:  2006-02       Impact factor: 3.126

5.  Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Gagan Deep; Suchitra Katiyar; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

Review 6.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

Review 7.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.

Authors:  Elizabeth Brandon-Warner; James A Sugg; Laura W Schrum; Iain H McKillop
Journal:  Cancer Lett       Date:  2009-11-08       Impact factor: 8.679

Review 9.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

10.  Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.

Authors:  Gagan Deep; Rahul Kumar; Anil K Jain; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-10       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.